These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5692410)

  • 21. [Measles in vaccinated children].
    Sejda J
    Cesk Pediatr; 1972 Aug; 27(8):401-3. PubMed ID: 5051739
    [No Abstract]   [Full Text] [Related]  

  • 22. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 25. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and immunoserological studies of measles vaccine inoculation].
    Ichinomiya K
    Nihon Shonika Gakkai Zasshi; 1968 Jul; 72(7):875-86. PubMed ID: 4178508
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
    [No Abstract]   [Full Text] [Related]  

  • 30. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 33. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 3. Clinical figure of natural measles after inoculation of measles raw vaccine and the rise and fall of blood antibody values].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):21-6. PubMed ID: 5691554
    [No Abstract]   [Full Text] [Related]  

  • 37. Seroconversion following measles immunisation.
    Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
    Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and immunoserological study of vaccine and spontaneous measles].
    Yoneda Y
    Nihon Shonika Gakkai Zasshi; 1967 Nov; 71(11):1406-16. PubMed ID: 5628247
    [No Abstract]   [Full Text] [Related]  

  • 40. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.